Study confirms FlowOx™ cost effectiveness and improved quality of life
A newly published health economic study confirms that FlowOx™ therapy in combination with nominal care appears to improve the health-related quality of life (QoL) of patients when compared with standard care and may also be cost saving for payors (NHS).
Study confirms FlowOx™ cost effectiveness and improved quality of life Read More »